Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,192 | 84 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $324.66 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $182.27 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $158.81 | 6 | $0 (2024) |
| Gilead Sciences, Inc. | $146.93 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $107.07 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $103.62 | 4 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $99.78 | 4 | $0 (2024) |
| ABBVIE INC. | $89.40 | 4 | $0 (2024) |
| QOL Medical, LLC | $77.43 | 3 | $0 (2024) |
| Novo Nordisk Inc | $74.78 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,495 | 58 | AstraZeneca Pharmaceuticals LP ($159.17) |
| 2023 | $696.72 | 26 | Bayer Healthcare Pharmaceuticals Inc. ($167.64) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.62 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/03/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: LIVER DISEASE | ||||||
| 11/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.70 | General |
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/07/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $23.72 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/05/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.59 | General |
| 10/22/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $35.89 | General |
| Category: CRITICAL CARE | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: LIVER DISEASE | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Gastroenterology | ||||||
| 10/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $119.20 | General |
| 10/08/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $27.09 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Gastroenterology | ||||||
About Wingnay Chernesky
Wingnay Chernesky is a Gerontology healthcare provider based in Catonsville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2023. The National Provider Identifier (NPI) number assigned to this provider is 1437830619.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Wingnay Chernesky has received a total of $2,192 in payments from pharmaceutical and medical device companies, with $1,495 received in 2024. These payments were reported across 84 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,192).
Practice Information
- Specialty Gerontology
- Location Catonsville, MD
- Active Since 07/31/2023
- Last Updated 06/04/2024
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1437830619
Products in Payments
- Kerendia (Drug) $182.27
- STELARA (Biological) $147.46
- FARXIGA (Drug) $140.81
- AIRSUPRA (Drug) $125.08
- OCALIVA (Drug) $99.78
- XIFAXAN (Drug) $92.39
- DUPIXENT (Biological) $79.65
- SUCRAID (Drug) $77.43
- TRELEGY ELLIPTA (Drug) $73.64
- INGREZZA (Drug) $66.70
- IBSRELA (Drug) $62.70
- Ozempic (Drug) $60.81
- Korlym (Drug) $59.12
- BREZTRI (Drug) $58.77
- ENTYVIO (Biological) $58.47
- IQIRVO (Drug) $53.27
- QULIPTA (Drug) $49.48
- EOHILIA (Drug) $45.15
- JARDIANCE (Drug) $44.81
- MYRISK (Device) $42.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.